#BREAKINGNEWS: Bayer & BlueRock Therapeutics announce positive results in our Phase I clinical study of a new investigational stem cell therapy for Parkinson’s disease (PD). An important milestone in our quest to meet unmet medical needs of those living with PD.
Read More: https://lnkd.in/ekY-krjA
Read More: https://lnkd.in/ekY-krjA